Generics group says branded drugmakers blocking $13B in annual savings

A study commissioned by the nation's largest generics trade group found the U.S. healthcare system could be saving billions of dollars if branded drug manufacturers weren't abusing federal programs meant to make higher-risk pharmaceuticals safer.